Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity

Journal of Immunology

Volumn 186, Issue 6, 2011, Pages 3346-3355

  Papenfuss, Tracey L ^a   Powell, Nicole D ^a   McClain, Melanie A ^a   Bedarf, Ashley ^a   Singh, Amber ^a   Gienapp, Ingrid E ^a   Shawler, Todd ^a   Whitacre, Caroline C ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CELL MARKER; ESTRIOL; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 6; PROTEIN B7 H3; PROTEIN B7 H4; PROTEIN PD L1; PROTEIN PD L2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNE DISEASE; CELL TRANSFER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH2 CELL;

ANIMALS; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ESTRIOL; FEMALE; G0 PHASE; GROWTH INHIBITORS; IMMUNE TOLERANCE; INFLAMMATION MEDIATORS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PREGNANCY; PREGNANCY PROTEINS; SPLEEN;

EID: 79953212582     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001322     Document Type: Article

References (89)

1. Whitacre, C. C. 2001. Sex differences in autoimmune disease. Nat. Immunol. 2: 777-780.
2. Whitacre, C. C., S. C. Reingold, and P. A. O'Looney. 1999. A gender gap in autoimmunity. Science 283: 1277-1278.
3. Offner, H., and M. Polanczyk. 2006. A potential role for estrogen in experimental autoimmune encephalomyelitis and multiple sclerosis. Ann. N. Y. Acad. Sci. 1089: 343-372.
4. McClain, M. A., N. N. Gatson, N. D. Powell, T. L. Papenfuss, I. E. Gienapp, F. Song, T. M. Shawler, A. Kithcart, and C. C. Whitacre. 2007. Pregnancy suppresses experimental autoimmune encephalomyelitis through immunoregulatory cytokine production. J. Immunol. 179: 8146-8152.
5. Voskuhl, R. R., and K. Palaszynski. 2001. Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neuroscientist 7: 258-270. (Pubitemid 32489119)
6. Head, K. A. 1998. Estriol: safety and efficacy. Altern. Med. Rev. 3: 101-113.
7. Taylor, M. 2005. "Bioidentical" estrogens: hope or hype? Sexuality, Reproduction & Menopause 3: 68-71.
8. Palaszynski, K. M., H. Liu, K. K. Loo, and R. R. Voskuhl. 2004. Estriol treatment ameliorates disease in males with experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J. Neuroimmunol. 149: 84-89.
9. Kim, S., S. M. Liva, M. A. Dalal, M. A. Verity, and R. R. Voskuhl. 1999. Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis. Neurology 52: 1230-1238.
10. Sicotte, N. L., S. M. Liva, R. Klutch, P. Pfeiffer, S. Bouvier, S. Odesa, T. C. Wu, and R. R. Voskuhl. 2002. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann. Neurol. 52: 421-428.
11. Soldan, S. S., A. I. Alvarez Retuerto, N. L. Sicotte, and R. R. Voskuhl. 2003. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J. Immunol. 171: 6267-6274.
12. Subramanian, S., A. Matejuk, A. Zamora, A. A. Vandenbark, and H. Offner. 2003. Oral feeding with ethinyl estradiol suppresses and treats experimental autoimmune encephalomyelitis in SJL mice and inhibits the recruitment of inflammatory cells into the central nervous system. J. Immunol. 170: 1548-1555. (Pubitemid 36139527)
13. Gold, S. M., and R. R. Voskuhl. 2009. Estrogen treatment in multiple sclerosis. J. Neurol. Sci. 286: 99-103.
14. Falcone, M., and B. R. Bloom. 1997. A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis. J. Exp. Med. 185: 901-907.
15. Shevach, E. M. 2000. Regulatory T cells in autoimmmunity*. Annu. Rev. Immunol. 18: 423-449.
16. Polanczyk, M. J., C. Hopke, A. A. Vandenbark, and H. Offner. 2006. Estrogen-mediated immunomodulation involves reduced activation of effector T cells, potentiation of Treg cells, and enhanced expression of the PD-1 costimulatory pathway. J. Neurosci. Res. 84: 370-378.
17. Polanczyk, M. J., C. Hopke, J. Huan, A. A. Vandenbark, and H. Offner. 2005. Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice. J. Neuroimmunol. 170: 85-92. (Pubitemid 41740909)
18. Liu, H. Y., A. C. Buenafe, A. Matejuk, A. Ito, A. Zamora, J. Dwyer, A. A. Vandenbark, and H. Offner. 2002. Estrogen inhibition of EAE involves effects on dendritic cell function. J. Neurosci. Res. 70: 238-248.
19. Polanczyk, M. J., R. E. Jones, S. Subramanian, M. Afentoulis, C. Rich, M. Zakroczymski, P. Cooke, A. A. Vandenbark, and H. Offner. 2004. T lymphocytes do not directly mediate the protective effect of estrogen on experimental autoimmune encephalomyelitis. Am. J. Pathol. 165: 2069-2077.
20. Steinman, R. M., D. Hawiger, and M. C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21: 685-711.
21. Steinman, R. M., and J. Banchereau. 2007. Taking dendritic cells into medicine. Nature 449: 419-426. (Pubitemid 47509552)
22. Griffiths, K. L., and H. C. O'Neill. 2008. Dendritic cells as immune regulators: the mouse model. J. Cell. Mol. Med. 12: 1909-1914.
23. Rutella, S., S. Danese, and G. Leone. 2006. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 108: 1435-1440. (Pubitemid 44316106)
24. Figdor, C. G., I. J. de Vries, W. J. Lesterhuis, and C. J. Melief. 2004. Dendritic cell immunotherapy: mapping the way. Nat. Med. 10: 475-480.
25. Szatmari, I., and L. Nagy. 2008. Nuclear receptor signalling in dendritic cells connects lipids, the genome and immune function. EMBO J. 27: 2353-2362.
26. Moser, M., T. De Smedt, T. Sornasse, F. Tielemans, A. A. Chentoufi, E. Muraille, M. Van Mechelen, J. Urbain, and O. Leo. 1995. Glucocorticoids down-regulate dendritic cell function in vitro and in vivo. Eur. J. Immunol. 25: 2818-2824.
27. Adorini, L., and G. Penna. 2009. Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists. Hum. Immunol. 70: 345-352.
28. Penna, G., and L. Adorini. 2000. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164: 2405-2411. (Pubitemid 30115468)
29. Piemonti, L., P. Monti, P. Allavena, M. Sironi, L. Soldini, B. E. Leone, C. Socci, and V. Di Carlo. 1999. Glucocorticoids affect human dendritic cell differentiation and maturation. J. Immunol. 162: 6473-6481.
30. + dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. J. Immunol. 161: 2804-2809.
31. Wada, Y., T. Hisamatsu, N. Kamada, S. Okamoto, and T. Hibi. 2009. Retinoic acid contributes to the induction of IL-12-hypoproducing dendritic cells. Inflamm. Bowel Dis. 15: 1548-1556.
32. Pulendran, B., H. Tang, and S. Manicassamy. 2010. Programming dendritic cells to induce T(H)2 and tolerogenic responses. Nat. Immunol. 11: 647-655.
33. Xiao, B. G., X. Liu, and H. Link. 2004. Antigen-specific T cell functions are suppressed over the estrogen-dendritic cell-indoleamine 2,3-dioxygenase axis. Steroids 69: 653-659. (Pubitemid 39297704)
34. Liu, Q., C. Zhang, A. Sun, Y. Zheng, L. Wang, and X. Cao. 2009. Tumor-educated CD11bhighIalow regulatory dendritic cells suppress T cell response through arginase I. J. Immunol. 182: 6207-6216.
35. MacMicking, J., Q. W. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15: 323-350.
36. Drew, P. D., J. A. Chavis, and R. Bhatt. 2003. Sex steroid regulation of microglial cell activation: relevance to multiple sclerosis. Ann. N. Y. Acad. Sci. 1007: 329-334.
37. Papenfuss, T. L., and C. C. Whitacre. 2009. Sex hormones, pregnancy, and immune function. In Hormones Brain and Behavior. A. P. Arnold, A. M. Etgen, S. E. Fahrbahc, R. T. Rubin, and D.W. Pfaff, eds. Elsevier, Oxford, U.K., p. 367-393.
38. Polazzi, E., and B. Monti. 2010, Microglia and neuroprotection: from in vitro studies to therapeutic applications. Prog. Neurobiol. 92: 293-315.
39. Kyurkchiev, D., E. Ivanova-Todorova, S. Hayrabedyan, I. Altankova, and S. Kyurkchiev. 2007. Female sex steroid hormones modify some regulatory properties of monocyte-derived dendritic cells. Am. J. Reprod. Immunol. 58: 425-433.
40. Carreras, E., S. Turner, V. Paharkova-Vatchkova, A. Mao, C. Dascher, and S. Kovats. 2008. Estradiol acts directly on bone marrow myeloid progenitors to differentially regulate GM-CSF or Flt3 ligand-mediated dendritic cell differentiation. J. Immunol. 180: 727-738.
41. Uemura, Y., T. Y. Liu, Y. Narita, M. Suzuki, and S. Matsushita. 2008. 17 Beta-estradiol (E2) plus tumor necrosis factor-alpha induces a distorted maturation of human monocyte-derived dendritic cells and promotes their capacity to initiate T-helper 2 responses. Hum. Immunol. 69: 149-157.
42. Bebo, B. F., Jr., A. Fyfe-Johnson, K. Adlard, A. G. Beam, A. A. Vandenbark, and H. Offner. 2001. Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J. Immunol. 166: 2080-2089. (Pubitemid 32114698)
43. Coquerelle, C., and M. Moser. 2010. DC subsets in positive and negative regulation of immunity. Immunol. Rev. 234: 317-334.
44. Maldonado-López, R., C. Maliszewski, J. Urbain, and M. Moser. 2001. Cytokines regulate the capacity of CD8alpha(+) and CD8alpha(2) dendritic cells to prime Th1/Th2 cells in vivo. J. Immunol. 167: 4345-4350.
45. Gold, S. M., and R. R. Voskuhl. 2009. Estrogen and testosterone therapies in multiple sclerosis. Prog. Brain Res. 175: 239-251.
46. Bhattacharya, P., A. Gopisetty, B. B. Ganesh, J. R. Sheng, and B. S. Prabhakar. 2011. GM-CSF-induced, bone-marrow-derived dendritic cells can expand natural Tregs and induce adaptive Tregs by different mechanisms. J. Leukoc. Biol. In press.
47. Maldonado-López, R., T. De Smedt, P. Michel, J. Godfroid, B. Pajak, C. Heirman, K. Thielemans, O. Leo, J. Urbain, and M. Moser. 1999. CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 189: 587-592.
48. Pulendran, B., J. L. Smith, G. Caspary, K. Brasel, D. Pettit, E. Maraskovsky, and C. R. Maliszewski. 1999. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA 96: 1036-1041.
49. Reis e Sousa, C., S. Hieny, T. Scharton-Kersten, D. Jankovic, H. Charest, R. N. Germain, and A. Sher. 1997. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 186: 1819-1829.
50. Jung, S., D. Unutmaz, P. Wong, G. Sano, K. De los Santos, T. Sparwasser, S. Wu, S. Vuthoori, K. Ko, F. Zavala, et al. 2002. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 17: 211-220.
51. Racke, M. K., A. Bonomo, D. E. Scott, B. Cannella, A. Levine, C. S. Raine, E. M. Shevach, and M. Röcken. 1994. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180: 1961-1966.
52. Pozzi, S., V. Benedusi, A. Maggi, and E. Vegeto. 2006. Estrogen action in neuroprotection and brain inflammation. Ann. N. Y. Acad. Sci. 1089: 302-323.
53. Stice, J. P., and A. A. Knowlton. 2008. Estrogen, NFkappaB, and the heat shock response. Mol. Med. 14: 517-527.
54. Yang, L., Y. Hu, and Y. Hou. 2006. Effects of 17beta-estradiol on the maturation, nuclear factor kappa B p65 and functions of murine spleen CD11c-positive dendritic cells. Mol. Immunol. 43: 357-366.
55. Zang, Y. C., J. B. Halder, J. Hong, V. M. Rivera, and J. Z. Zhang. 2002. Regulatory effects of estriol on T cell migration and cytokine profile: inhibition of transcription factor NF-kappa B. J. Neuroimmunol. 124: 106-114.
56. Du, C., and S. Sriram. 1998. Mechanism of inhibition of LPS-induced IL-12p40 production by IL-10 and TGF-beta in ANA-1 cells. J. Leukoc. Biol. 64: 92-97.
57. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3: 133-146.
58. Pulendran, B., J. Banchereau, E. Maraskovsky, and C. Maliszewski. 2001. Modulating the immune response with dendritic cells and their growth factors. Trends Immunol. 22: 41-47. (Pubitemid 32675280)
59. Pettersson, A., C. Ciumas, V. Chirsky, H. Link, Y. M. Huang, and B. G. Xiao. 2004. Dendritic cells exposed to estrogen in vitro exhibit therapeutic effects in ongoing experimental allergic encephalomyelitis. J. Neuroimmunol. 156: 58-65.
60. Tuettenberg, A., S. Fondel, K. Steinbrink, A. H. Enk, and H. Jonuleit. 2010. CD40 signalling induces IL-10-producing, tolerogenic dendritic cells. Exp. Dermatol. 19: 44-53.
61. Pulendran, B., P. Kumar, C. W. Cutler, M. Mohamadzadeh, T. Van Dyke, and J. Banchereau. 2001. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J. Immunol. 167: 5067-5076. (Pubitemid 33009740)
62. Yang, Y., J. Weiner, Y. Liu, A. J. Smith, D. J. Huss, R. Winger, H. Peng, P. D. Cravens, M. K. Racke, and A. E. Lovett-Racke. 2009. T-bet is essential for encephalitogenicity of both Th1 and Th17 cells. J. Exp. Med. 206: 1549-1564.
63. Laouar, Y., T. Town, D. Jeng, E. Tran, Y. Wan, V. K. Kuchroo, and R. A. Flavell. 2008. TGF-beta signaling in dendritic cells is a prerequisite for the control of autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 105: 10865-10870.
64. Weiner, H. L. 2001. Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. Microbes Infect. 3: 947-954. (Pubitemid 32835309)
65. Mellor, A. L., and D. H. Munn. 2004. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4: 762-774.
66. Mellor, A. L., B. Baban, P. Chandler, B. Marshall, K. Jhaver, A. Hansen, P. A. Koni, M. Iwashima, and D. H. Munn. 2003. Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J. Immunol. 171: 1652-1655.
67. Greenwald, R. J., G. J. Freeman, and A. H. Sharpe. 2005. The B7 family revisited. Annu. Rev. Immunol. 23: 515-548.
68. Hashiguchi, M., H. Kobori, P. Ritprajak, Y. Kamimura, H. Kozono, and M. Azuma. 2008. Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses. Proc. Natl. Acad. Sci. USA 105: 10495-10500.
69. Francisco, L. M., P. T. Sage, and A. H. Sharpe. 2010. The PD-1 pathway in tolerance and autoimmunity. Immunol. Rev. 236: 219-242.
70. Salama, A. D., T. Chitnis, J. Imitola, M. J. Ansari, H. Akiba, F. Tushima, M. Azuma, H. Yagita, M. H. Sayegh, and S. J. Khoury. 2003. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J. Exp. Med. 198: 71-78.
71. Prasad, D. V., T. Nguyen, Z. Li, Y. Yang, J. Duong, Y. Wang, and C. Dong. 2004. Murine B7-H3 is a negative regulator of T cells. J. Immunol. 173: 2500-2506. (Pubitemid 39063108)
72. Sica, G. L., I. H. Choi, G. Zhu, K. Tamada, S. D. Wang, H. Tamura, A. I. Chapoval, D. B. Flies, J. Bajorath, and L. Chen. 2003. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 18: 849-861. (Pubitemid 36776432)
73. Suh, W. K., B. U. Gajewska, H. Okada, M. A. Gronski, E. M. Bertram, W. Dawicki, G. S. Duncan, J. Bukczynski, S. Plyte, A. Elia, et al. 2003. The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses. Nat. Immunol. 4: 899-906.
74. Ling, V., P. W. Wu, V. Spaulding, J. Kieleczawa, D. Luxenberg, B. M. Carreno, and M. Collins. 2003. Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss. Genomics 82: 365-377. (Pubitemid 36952307)
75. Fukushima, A., T. Sumi, K. Fukuda, N. Kumagai, T. Nishida, T. Yamazaki, H. Akiba, K. Okumura, H. Yagita, and H. Ueno. 2007. B7-H3 regulates the development of experimental allergic conjunctivitis in mice. Immunol. Lett. 113: 52-57.
76. Prasad, D. V., S. Richards, X.M.Mai, and C. Dong. 2003. B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity 18: 863-873. (Pubitemid 36776433)
77. Zang, X., P. Loke, J. Kim, K. Murphy, R. Waitz, and J. P. Allison. 2003. B7x: a widely expressed B7 family member that inhibits T cell activation. Proc. Natl. Acad. Sci. USA 100: 10388-10392.
78. Coyle, A. J., and J. C. Gutierrez-Ramos. 2001. The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nat. Immunol. 2: 203-209.
79. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
80. Awasthi, A., and V. K. Kuchroo. 2009. Th17 cells: from precursors to players in inflammation and infection. Int. Immunol. 21: 489-498.
81. Kimura, A., and T. Kishimoto. 2010. IL-6: regulator of Treg/Th17 balance. Eur. J. Immunol. 40: 1830-1835.
82. Matejuk, A., A. C. Bakke, C. Hopke, J. Dwyer, A. A. Vandenbark, and H. Offner. 2004. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis. J. Neurosci. Res. 77: 119-126.
83. Matejuk, A., and M. Afentoulis. 2006. Association of CD45(dim)VLA-4 (+) cells with the NKT cell lineage and their selective expression of IL-13, IP-15, and CCR3 transcripts. Arch. Immunol. Ther. Exp. (Warsz.) 54: 183-191. (Pubitemid 44257339)
84. Zhang, Q. H., Y. Z. Hu, J. Cao, Y. Q. Zhong, Y. F. Zhao, and Q. B. Mei. 2004. Estrogen influences the differentiation, maturation and function of dendritic cells in rats with experimental autoimmune encephalomyelitis. Acta Pharmacol. Sin. 25: 508-513.
85. Xu, Y., Y. Zhan, A. M. Lew, S. H. Naik, and M. H. Kershaw. 2007. Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking. J. Immunol. 179: 7577-7584.
86. Kovats, S., and E. Carreras. 2008. Regulation of dendritic cell differentiation and function by estrogen receptor ligands. Cell. Immunol. 252: 81-90.
87. Paharkova-Vatchkova, V., R. Maldonado, and S. Kovats. 2004. Estrogen preferentially promotes the differentiation of CD11c+ CD11b(intermediate) dendritic cells from bone marrow precursors. J. Immunol. 172: 1426-1436. (Pubitemid 38116784)
88. Härkönen, P. L., and H. K. Väänänen. 2006. Monocyte-macrophage system as a target for estrogen and selective estrogen receptor modulators. Ann. N. Y. Acad. Sci. 1089: 218-227.
89. Steinman, R. M., D. S. Lustig, and Z. A. Cohn. 1974. Identification of a novel cell type in peripheral lymphoid organs of mice. 3. Functional properties in vivo. J. Exp. Med. 139: 1431-1445.